Masaaki Eto
Kobe, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Population pharmacokinetics and exposure-clinical outcome relationship of remdesivir major metabolite GS-441524 in patients with moderate and severe COVID-19.
Journal: CPT: pharmacometrics & systems pharmacology
Published: August 22, 2022
Population Pharmacokinetics of Nivolumab in Japanese Patients with Nonsmall Cell Lung Cancer.
Journal: Therapeutic drug monitoring
Published: February 25, 2022
Association between 25-hydroxyvitamin D levels and COVID-19 severity.
Journal: Clinical nutrition ESPEN
Published: January 11, 2022
Population pharmacokinetics of favipiravir in patients with COVID-19.
Journal: CPT: pharmacometrics & systems pharmacology
Published: March 01, 2021
Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID-19.
Journal: Clinical and translational science
Published: May 15, 2020
Plasma concentration of amitriptyline and metabolites after resuscitation from cardiopulmonary arrest following an overdose: A case report.
Journal: Clinical case reports
Published: January 17, 2020
Familial type III hyperlipoproteinemia
Journal: Nihon rinsho. Japanese journal of clinical medicine
Published: November 12, 2013
Apolipoprotein B-48 to triglyceride ratio is a novel and useful marker for detection of type III hyperlipidemia after antihyperlipidemic intervention.
Journal: Journal of atherosclerosis and thrombosis
Published: August 11, 2012
Background to discuss guidelines for control of plasma HDL-cholesterol in Japan.
Journal: Journal of atherosclerosis and thrombosis
Published: January 14, 2012
Management of type IIb dyslipidemia.
Journal: Journal of atherosclerosis and thrombosis
Published: December 06, 2011
Diagnosis and management of type I and type V hyperlipoproteinemia.
Journal: Journal of atherosclerosis and thrombosis
Published: December 02, 2011
Showing 1-12 of 12
Last Updated: 09/26/2026